Pricing Log in Create free account

iBio, Inc. (IBIO) vs ImageneBio, Inc. (IMA)

iBio, Inc. and ImageneBio, Inc. are both Biotechnology companies. iBio, Inc. and ImageneBio, Inc. are of similar size ($47.6M and $45.7M). iBio, Inc. grew revenue faster over the last twelve months: −66.6% against −68.0%. Across the 13 metrics below, iBio, Inc. leads on 7 and ImageneBio, Inc. on 6.

Valuation

Metric IBIO IMA Biotechnology median
P/E n/m n/m 8.50
P/S 118.71 10.63 9.71
P/B 0.93 0.46 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.19 n/m 0.64
EV/Sales (9.70) 2.52 9.21
Earnings yield (44.16%) (129.11%) (33.15%)
Free cash flow yield (30.24%) (79.05%) (25.50%)

Profitability

Metric IBIO IMA Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.70%) (41.34%) (56.36%)
Return on assets (54.04%) (38.34%) (48.04%)
Return on invested capital 0.00% (622.37%) 0.00%

Growth

Metric IBIO IMA Biotechnology median
Revenue growth (TTM) (66.55%) (67.95%) 6.02%
EPS growth (last fiscal year) 81.71% 21.27% 30.26%
Revenue growth, 5-year CAGR (42.83%) (38.64%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IBIO IMA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.85 21.47 4.72
Net debt to EBITDA 2.57 2.85 0.96

Dividend

Metric IBIO IMA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IBIO IMA Biotechnology median
Market cap 47.63m 45.74m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack